Efficacy of Cetuximab in the Treatment of Menetrier's Disease
about
Ménétrier's Disease: Its Mimickers and PathogenesisFrom wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.Protein expression signatures for inhibition of epidermal growth factor receptor-mediated signaling.Disease recurrence following cetuximab completion and declining a gastrectomy: what next to manage Ménétriers disease?Distinguishing Ménétrier's disease from its mimicsIn-depth proteomic analysis of nonsmall cell lung cancer to discover molecular targets and candidate biomarkers.A case of Menetrier's disease without Helicobacter pylori or hypoalbuminemia[18F]FLT-PET to predict pharmacodynamic and clinical response to cetuximab therapy in Ménétrier's disease.A case of Ménétrier's disease localized to the gastric antrum without helicobacter infection or hypoalbuminemiaMénétrier's disease of the stomach: a clinical challenge.Evolving molecular targets in the treatment of nonmalignant gastrointestinal diseases.Pierre Ménétrier and his disease.A Concurrent Case of Ménétrier's Disease and Signet Ring Carcinoma.Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states.Robot-assisted laparoscopic gastrectomy for Menetrier's disease.MIB2 variants altering NOTCH signalling result in left ventricle hypertrabeculation/non-compaction and are associated with Ménétrier-like gastropathy.
P2860
Q26774506-7BEF35F5-F18C-431B-A41A-35C7E95B6880Q33926726-422EF071-8FAE-4B07-A0AA-2F259FD81BD0Q34093266-3C0080AF-DCBB-45DC-A752-C6027AD8FFF8Q34151838-F86C8196-7E4B-40B4-88A2-166FA610AEA8Q34487309-5D6F93E6-8D01-44D9-B3A2-6588F6B97964Q36386730-603911BE-5BA0-4647-9C32-5A359D2F6C0DQ36431541-CA563763-2958-4A7A-B940-AA6866879D98Q36528174-AF9EB06C-0C1D-4911-B9FA-32CE27859C49Q37204484-34087EEC-A968-4093-B3C9-47A7791FBCB5Q37935604-A084439C-22AD-44B2-A17E-903B4460617FQ38029235-29D93DD6-B2A4-4027-9CB2-5C0CFCE9013DQ38072908-80855AFE-36F0-4BF2-AE95-D9E0B783873AQ39500817-9E98F11F-EAD2-4AC3-867A-958284BF185BQ40112268-5CEB892F-B56B-44B3-8346-195F6C68A382Q48109868-D64F69F8-9615-471F-A06D-48E7E746D54AQ51067118-B8F24E5C-9B9B-467D-9708-03933A2022CD
P2860
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
description
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artikull shkencor
@sq
artículu científicu espublizáu en 2009
@ast
scientific article (publication date: 25 November 2009)
@en
wetenschappelijk artikel
@nl
wissenschaftlicher Artikel
@de
наукова стаття, опублікована в листопаді 2009
@uk
مقالة علمية (نشرت في 25-11-2009)
@ar
name
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
@ast
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
@en
type
label
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
@ast
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
@en
prefLabel
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
@ast
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
@en
P2093
P2860
P1476
Efficacy of Cetuximab in the Treatment of Menetrier's Disease
@en
P2093
A. M. Abtahi
B. La Fleur
C. D. Lind
D. C. Liebler
G. D. Ayers
J. R. Goldenring
J. Tanksley
M. K. Washington
R. J. C. Slebos
P2860
P304
8ra18-8ra18
P356
10.1126/SCITRANSLMED.3000320
P407
P577
2009-11-25T00:00:00Z